A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Stem cells created from the skin of patients with a rare form of diabetes have been used to elucidate an important biochemical pathway for beta-cell failure in diabetes.
Drs. Rudolph Leibel and Michael Rosenbaum are members of a multi-center collaboration that plans to test competing hypotheses of obesity and weight gain.
Study of insulin-producing cells derived from skin of diabetes patients shows utility of iPS cells for study of human disease and as potential therapy.
Obese adolescents are more likely than their normal-weight counterparts to have hearing loss – results of a new study led by Columbia’s Dr. Anil Lalwani.